SOFTOX SOLUTIONS NK 002
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more
Market Cap & Net Worth: SOFTOX SOLUTIONS NK 002 (6FV)
SOFTOX SOLUTIONS NK 002 (F:6FV) has a market capitalization of $11.96 Million (€11.65 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #28524 globally and #3128 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SOFTOX SOLUTIONS NK 002's stock price €0.01 by its total outstanding shares 2330416994 (2.33 Billion).
SOFTOX SOLUTIONS NK 002 Market Cap History: 2021 to 2026
SOFTOX SOLUTIONS NK 002's market capitalization history from 2021 to 2026. Data shows change from $13.06 Billion to $11.96 Million (-75.63% CAGR).
SOFTOX SOLUTIONS NK 002 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SOFTOX SOLUTIONS NK 002's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6FV by Market Capitalization
Companies near SOFTOX SOLUTIONS NK 002 in the global market cap rankings as of March 19, 2026.
Key companies related to SOFTOX SOLUTIONS NK 002 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
SOFTOX SOLUTIONS NK 002 Historical Marketcap From 2021 to 2026
Between 2021 and today, SOFTOX SOLUTIONS NK 002's market cap moved from $13.06 Billion to $ 11.96 Million, with a yearly change of -75.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €11.96 Million | 0.00% |
| 2025 | €11.96 Million | +400.00% |
| 2024 | €2.39 Million | -99.52% |
| 2023 | €502.34 Million | -90.43% |
| 2022 | €5.25 Billion | -59.80% |
| 2021 | €13.06 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SOFTOX SOLUTIONS NK 002 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.96 Million USD |
| MoneyControl | $11.96 Million USD |
| MarketWatch | $11.96 Million USD |
| marketcap.company | $11.96 Million USD |
| Reuters | $11.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.